DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Melcher C, Schochter F, Albrecht S et al.
DETECT IV – a multicenter, single arm, phase II study evaluating the efficacy of Everolimus in combination with endocrine therapy in patients with HER2-negative, hormone-receptor positive metastatic breast cancer and exclusively HER2-negative circulating tumor cells (CTCs).
Oncol Res Treat 2014;
37: 29-29
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.